Back to results
CompletedPhase 2

Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer

NCT03243838

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Guangdong general hospital

Guangzhou, Guangdong, China

+1 additional location

View on ClinicalTrials.gov